MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Rotenone induces astrocyte-mediated non-cell autonomous dopaminergic neurotoxicity

I. Miyazaki, S. Murakami, R. Kikuoka, N. Isooka, Y. Kitamura, M. Asanuma (Okayama, Japan)

Meeting: 2017 International Congress

Abstract Number: 917

Keywords: Dopaminergic neurons, Parkinsonism, Rotenone

Session Information

Date: Wednesday, June 7, 2017

Session Title: Neuropharmacology

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: In this study, we examined involvement of astrocytes in rotenone-induced dopaminergic neurotoxicity using primary cultured cells.

Background: Several studies reported that pesticide exposure, such as rotenone or paraquat, increased the incidence of Parkinson’s disease (PD). Therefore, exposure to pesticides is thought as a potential environmental factor to play important roles in the pathogenesis of PD. Rotenone is often used to induce PD-like pathology in the central nervous system and enteric nervous system. We previously reported that subcutaneous infusion of rotenone in mice resulted in neurodegeneration and glial activation not only in the nigrostriatal pathway but also in the olfactory bulb and ascending colon, and that these effects were region-specific but not serial changes.

Methods: Primary cultured neurons and astrocytes were prepared from the mesencephalon of Sprague-Dawley rat embryos at 15 days of gestation. Enriched neuronal cultures or neuron-astrocyte co-cultures were treated with rotenone for 48 h. The treated cells were fixed and reacted with the mouse anti-tyrosine hydroxylase antibody. We also examined the effects of rotenone-treated astrocytes on survival of dopaminergic neurons using conditioned media from rotenone-treated astrocytes. Furthermore, we examined differentially displayed molecules and antioxidative property in astrocytes after rotenone treatment.

Results: Rotenone exposure significantly decreased dopaminergic neurons in neuron-astrocyte co-cultures, but not in enriched neuronal cultures. In addition, dopaminergic neurotoxicity was induced by treatment with conditioned media from rotenone-treated astrocytes. Rotenone treatment induced moderate up-regulation of inflammatory cytokines in conditioned media of astrocytes. Furthermore, the pesticide significantly decreased the secretion of metallothionein, which is an antioxidative molecule, from astrocytes.

Conclusions: These results showed that rotenone induced astrocyte-mediated non-cell autonomous dopaminergic neurodegeneration, and suggested that astrocyte dysfunction plays an important role in rotenone neurotoxicity. (The part of this paper was presented at 90th Annual Meeting of the Japanese Pharmacological Society on March 16, 2017.)

To cite this abstract in AMA style:

I. Miyazaki, S. Murakami, R. Kikuoka, N. Isooka, Y. Kitamura, M. Asanuma. Rotenone induces astrocyte-mediated non-cell autonomous dopaminergic neurotoxicity [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/rotenone-induces-astrocyte-mediated-non-cell-autonomous-dopaminergic-neurotoxicity/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/rotenone-induces-astrocyte-mediated-non-cell-autonomous-dopaminergic-neurotoxicity/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley